Cannabinoids have established themselves as therapeutic options in the treatment of pain in recent years. Nevertheless, patients can experience problems when using them, particularly with regard to tolerance. A new aqueous nanodispersion appears to be able to eliminate these problems.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
Related Topics
You May Also Like
- From statins to metformin
Preventive pharmacology and longevity
- Important basics and studies on cancer and the psyche
Interplay between cancer and mental illness
- From symptom to diagnosis
Abdominal pain – angiosarcoma
- Pediatric epilepsy
Diazepam nasal spray for infants
- Findings from research on the generalization of exposure therapy
Treatment of comorbid anxiety
- Symptom-free despite asthma?
Asthma treatment requirements have increased
- Phytotherapy for rhinosinusitis
Evidence, active substances and clinical classification for medical practice
- Contact eczema